FDA considers adding a dozen peptides to its bulk drug compounding list RAPS Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP 1 compounding while @martymakary is photographed holding bootleg # Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy FDA Peptide Reclassification 2026: What Researchers Want FDA Peptide Reclassification 2026: What Researchers Want